PINK
CHYHY

Chr Hansen Holding A/S ADR

Specialty Chemicals
Basic Materials

Prices are adjusted according to historical splits.

Chr Hansen Holding A/S ADR Stock Price

Vitals

Today's Low:
$16.39
Today's High:
$16.8
Open Price:
$16.8
52W Low:
$11.7341
52W High:
$20.61
Prev. Close:
$16.92
Volume:
526819

Company Statistics

Market Cap.:
$10.01 billion
Book Value:
3.352
Revenue TTM:
$1.29 billion
Operating Margin TTM:
26.58%
Gross Profit TTM:
$676.50 million
Profit Margin:
17.67%
Return on Assets TTM:
6.64%
Return on Equity TTM:
13.33%

Company Profile

Chr Hansen Holding A/S ADR had its IPO on under the ticker symbol CHYHY.

The company operates in the Basic Materials sector and Specialty Chemicals industry. Chr Hansen Holding A/S ADR has a staff strength of 3,834 employees.

Stock update

Shares of Chr Hansen Holding A/S ADR opened at $16.8 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $16.39 - $16.8, and closed at $16.44.

This is a -2.84% slip from the previous day's closing price.

A total volume of 526,819 shares were traded at the close of the day’s session.

In the last one week, shares of Chr Hansen Holding A/S ADR have increased by +1.51%.

Chr Hansen Holding A/S ADR's Key Ratios

Chr Hansen Holding A/S ADR has a market cap of $10.01 billion, indicating a price to book ratio of 50.8811 and a price to sales ratio of 7.8011.

In the last 12-months Chr Hansen Holding A/S ADR’s revenue was $1.29 billion with a gross profit of $676.50 million and an EBITDA of $427.10 million. The EBITDA ratio measures Chr Hansen Holding A/S ADR's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Chr Hansen Holding A/S ADR’s operating margin was 26.58% while its return on assets stood at 6.64% with a return of equity of 13.33%.

In Q0.66666666666667, Chr Hansen Holding A/S ADR’s quarterly earnings growth was a positive 0% while revenue growth was a positive 11.3%.

Chr Hansen Holding A/S ADR’s PE and PEG Ratio

Forward PE
34.4828
Trailing PE
40.2234
PEG
3.7945

Its diluted EPS in the last 12-months stands at $0.47 per share while it has a forward price to earnings multiple of 34.4828 and a PEG multiple of 3.7945. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Chr Hansen Holding A/S ADR’s profitability.

Chr Hansen Holding A/S ADR stock is trading at a EV to sales ratio of 7.5752 and a EV to EBITDA ratio of 26.2755. Its price to sales ratio in the trailing 12-months stood at 7.8011.

Chr Hansen Holding A/S ADR stock pays annual dividends of $0.95 per share, indicating a yield of 2.7% and a payout ratio of 50.82%.

Balance sheet and cash flow metrics

Total Assets
$3.33 billion
Total Liabilities
$315.60 million
Operating Cash Flow
$0
Capital Expenditure
$29.30 million
Dividend Payout Ratio
50.82%

Chr Hansen Holding A/S ADR ended 2024 with $3.33 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $3.33 billion while shareholder equity stood at $1.79 billion.

Chr Hansen Holding A/S ADR ended 2024 with $0 in deferred long-term liabilities, $315.60 million in other current liabilities, 177100000.00 in common stock, $1.63 billion in retained earnings and $1.51 billion in goodwill. Its cash balance stood at $54.90 million and cash and short-term investments were $54.90 million. The company’s total short-term debt was $65,800,000 while long-term debt stood at $0.

Chr Hansen Holding A/S ADR’s total current assets stands at $517.20 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $194.00 million compared to accounts payable of $113.80 million and inventory worth $211.00 million.

In 2024, Chr Hansen Holding A/S ADR's operating cash flow was $0 while its capital expenditure stood at $29.30 million.

Comparatively, Chr Hansen Holding A/S ADR paid $0.51 in dividends in 2024.

Other key metrics

Current Trading Price
$16.44
52-Week High
$20.61
52-Week Low
$11.7341
Analyst Target Price
$

Chr Hansen Holding A/S ADR stock is currently trading at $16.44 per share. It touched a 52-week high of $20.61 and a 52-week low of $20.61. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $17.7 and 200-day moving average was $18.1 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 1.5% are held by institutions.

Frequently Asked Questions About Chr Hansen Holding A/S ADR

The stock symbol (also called stock or share ticker) of Chr Hansen Holding A/S ADR is CHYHY

The IPO of Chr Hansen Holding A/S ADR took place on

Similar Industry Stocks (Specialty Chemicals)

Last Price
Chg
Chg%
$0.44
0
0%
$41.04
1.19
+2.99%
$3.24
-0.08
-2.41%
$41.69
0
0%
$61.9
-1.11
-1.76%
$56.24
-5.9
-9.49%
Beardsell Limited (BEARDSELL)
$34.2
-1.75
-4.87%
$20.76
0.09
+0.44%
$13.5
-0.16
-1.17%
Swan Energy Limited (SWANENERGY)
$279.05
-22.65
-7.51%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. The company operates through Food Cultures & Enzymes, and Health & Nutrition segments. The Food Cultures & Enzymes segment produces and sells various cultures, enzymes, and probiotic products that determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of various consumer products in the food industry, primarily in the dairy industry. The Health & Nutrition segment produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. It has a strategic collaboration with UPL Ltd. to develop and commercialize microbial-based bio solutions for sustainable agriculture. The company was founded in 1843 and is headquartered in Hørsholm, Denmark.

Address

Boege AllE 10-12, Horsholm, Denmark, 2970